Suncoast Skin Solutions Surpasses 48,000 Five-Star Patient Reviews
Florida dermatology practice reaches milestone across more than 40 locations LUTZ, FL / ACCESS Newswire / November 2, 2026 /...
Melanoma
Medical Care Technologies Inc. (OTCID:MDCE) Delivers Stronger Melanoma Scan Beta Readout on Expanded Human-Submitted Dataset
Expanded Human-Submitted Image Review Shows Image-Quality Pass Rate of 86%, Body-Map Registration of 89% and Change-Over-Time Alignment of 91% MESA,...
Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution
This international award, honoring “the best of the best” in medical innovation, represents yet another important external recognition of AI-Immunology™...
Immuneering Reports Third Quarter 2026 Financial Results and Provides Business Updates
 - Phase 2 pancreatic cancer follow-up extended as patients on atebimetinib combinations live longer than projected - - Updated Phase...
Immunocore will present Phase 1 data for brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma, during a late-breaking oral session at the 2026 SITC meeting
Immunocore will present Phase 1 data for brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma, during a late-breaking oral session...
iOnctura to present late-breaking data on roginolisib in immunotherapy-resistant NSCLC at SITC
Data from the ongoing PULMO-01 clinical study to be presented on November 6, 2026, at SITC 2026Roginolisib is the first...
Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precision Medicine Strategy
Live Webcast at 8:30 a.m. ET on Thursday, October 29, 2026 PHILADELPHIA, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics,...
Medical Care Technologies Inc. (OTCID:MDCE) Highlights Accelerating Revenue Momentum, AI Commercialization and Expanding Subsidiaries
Company Builds on Strongest Quarterly Revenue Outlook in the Past Year While Prioritizing Commercial Execution, Financial Performance and Disciplined Capital...
Former FDA Head Steve Hahn Joins BreakBio, a Personalized Cancer Drug Company, as Advisor
MIAMI, Oct. 26, 2026 /PRNewswire/ -- BreakBio, a biotech company developing personalized drugs for cancer, today announced that Stephen M....
NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
In 24 heavily pre-treated patients with advanced primary cutaneous melanoma whose cancer had progressed after multiple prior lines of therapy...
Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting
IMA402 PRAME bispecific continues to demonstrate encouraging anti-tumor activity in multiple indications, alongside a favorable safety profileIMA402 achieved a cORR...
Medical Care Technologies Inc. (OTCID:MDCE) Engages Task-Based Software Technicians and External Platforms to Accelerate Technology and Enterprise Expansion
Company Adds Specialized Technical Capacity to Speed Development Across AI Platforms, Software Offerings, and Consulting Services MESA, AZ / ACCESS...
Moderna Named a Top Employer by Science for Twelfth Consecutive Year
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a...
Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01
EVX-01 induced an immune response in all patients in the trial with 89% of the vaccine neoantigens generating potent specific...
GLOBAL STREAMERS TURN WORLD GAMING DAY INTO A GLOBAL FIGHT FOR CANCER SUPPORT WITH LA ROCHE-POSAY USA ON DISCORD
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- During World Gaming Day today, La Roche-Posay will host a new edition of its...
GLOBAL STREAMERS TURN WORLD GAMING DAY INTO A GLOBAL FIGHT FOR CANCER SUPPORT WITH LA ROCHE-POSAY USA ON DISCORD
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- During World Gaming Day today, La Roche-Posay will host a new edition of its...
Avance Clinical to Meet European Biotechs at ESMO Congress 2026 and Appoints Wendy Hamon as Senior Vice President, Oncology Center of Excellence
Executive Medical Director Dr George Peoples to discuss oncology programs from preclinical through Phase II in Madrid Wendy Hamon Wendy...
Medical Care Technologies Inc. (OTCID:MDCE) Advances Melanoma Scan Beta With Next-Week Results Posting
Larger Human-Submitted Dataset Now Ready for Public Technical Update as Testing Continues MESA, AZ / ACCESS Newswire / October 20,...
Medical Care Technologies Inc. (OTCID:MDCE) Outlines Path to Scale AI-Powered Software Revenue After $250,000 First Agreement
Company Points to Four Active Tracks - Software Monetization, StrainScan Pro Outreach, Subsidiary Collectibles Flow, and Health Imaging R&D -...
iOnctura appoints Paul Sekhri as Chair of its Board of Directors
Paul Sekhri is a life science executive with more than 35 years of experience building and leading companies from early...